The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear$244.81Fair value$390.85Bull$619.39
FairClose
52-week traded range
52W low $141.1752W high $244.18
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading below the consensus fair value
Universal Health Services closed at $174.83, 55.3% below the consensus fair value of $390.85 drawn from 8 valuation models.
Financial DNA score 66/100 — Strong. P/E of 7.6x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
$261.55
+49.6%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
$255.68
+46.2%
√(22.5 × EPS × BVPS)
EPS=23.1, BVPS=125.78
P/E Fair Value
$462.00
+164.3%
EPS × 20x (sector P/E)
EPS=23.1, Sector P/E=20x
Peter Lynch (PEG)
$325.48
+86.2%
EPS × Growth% (PEG = 1 is fair)
EPS=23.1, g=14.1%
EV/EBITDA
$619.39
+254.3%
(EBITDA × 17x − Net Debt) ÷ Shares
EBITDA=2.61B
Book Value (P/B)
$434.25
+148.4%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=125.78, ROE=19.8%, g=6%, r=10%
Reverse DCF
$174.83
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: -6.3% | Historical: 14.1%
Margin of Safety
$244.81
+40.0%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=326.41, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.